Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Oregon for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Oregon only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Oregon (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Marc Uemura (NPI 1487971081)

Field	Value
Entity Type	Individual
Organization	Marc Uemura
Address	520 Country Club
City	Eugene
State	OR
ZIP	97401
Taxonomy	Internal Medicine Physician
NPI Enumerated	April 23, 2010

Payer Source	Total Paid
Medicare	$1M
Medicaid	$0

Key Findings

Medicare revenue is highly concentrated: Total Medicare revenue is $1M and the precomputed top 3 Medicare codes by revenue account for 91.3% of this provider's total Medicare revenue. The single largest line item is J9271, which alone generated $657.9K (63.3% of Medicare revenue), followed by J9299 at $265K (25.5%).

The provider’s code mix indicates an oncology/infusion-focused practice: dominant use of high-cost immunotherapy agents (J9271 and J9299) plus chemotherapy administration codes such as 96413 and add-on infusion codes (96417, 96415, 96365) points to routine in-office administration of cancer therapy and supportive medications. The presence of M0010 (M0010 – Enhancing oncology model monthly enhanced oncology services) further aligns billing with oncology care models and enhanced oncology service payments.

Scale and claims activity confirm heavy utilization of specific drugs: J9271 shows 15.3K claims with an average paid per claim of $43 and $657.9K revenue, while J9299 shows 11K claims with an average paid per claim of $24 and $265K revenue. Both codes make up the vast majority of billings and place the provider in the middle of national peer distributions — J9271 ranks #665 of 1841 providers (64th percentile; typical, unremarkable volume for this code) and J9299 ranks #323 of 505 providers (36th percentile; typical, unremarkable volume for this code).

Competitive standing is modest rather than dominant: despite very large absolute drug volumes for this individual, national ranking for J9271 and J9299 places the provider in typical peer percentiles (64th and 36th respectively) within sizeable specialty peer pools, so the practice is a meaningful but not leading national actor for these drug administrations. Other chemotherapy administration codes such as 96413 rank #2113 of 7514 providers (72th percentile; typical, unremarkable volume for this code), reinforcing a profile of typical specialty-level activity rather than outlier dominance.

The provider is effectively single-payer with respect to public programs: there is no Medicaid billing on file (none below), so the practice’s public-payer exposure is concentrated in Medicare only. This payer mix means revenue and utilization trends will be driven by Medicare coverage and reimbursement for oncology drugs and infusion services rather than dual-payer dynamics.

Ancillary E/M and lab services are present but represent a small share of revenue: 99213 generated $25.7K (402 claims, $64 avg paid/claim) but only 2.5% of Medicare revenue, while common lab/venipuncture codes such as 36415 ($6.3K, 784 claims) and 80053 ($6K, 604 claims) appear to support infusion workflows. Many of these non-drug codes have relatively high percentile ranks (for example 36415 ranks in the 95th percentile and 99213 in the 91th percentile) but are still labeled in the dataset as typical, unremarkable volume for those codes, indicating routine supportive services accompanying infusion care.

Tenure and enrollment indicate an established provider: the NPI was enumerated on 2010-04-23 (~16 years ago), so this billing pattern reflects an established practice rather than a recent entrant; longevity increases the plausibility that the concentrated oncology drug administration model is an intentional, sustained service line.

Business risk and operational implications: the heavy dependence on two immunotherapy agents (J9271 and J9299) that together account for the majority of Medicare revenue creates exposure to changes in drug pricing, Medicare coverage decisions, and utilization management. Operationally, the combination of high-volume drug administration claims and routine supportive E/M and lab codes suggests a facility with infusion capacity, staffing for chemotherapy administration, and billing processes tuned to oncology drug reimbursement.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

53 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J9271	Injection, pembrolizumab, 1 mg	15,300	$40	$657.9K
J9299	Injection, nivolumab, 1 mg	11,040	$20	$265K
96413	Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These…	270	$100	$26.3K
99213	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the…	400	$60	$25.7K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	70	$100	$6.4K
36415	In this procedure, the provider inserts a needle into a vein to collect a blood sample.	780	$10	$6.3K
80053	The lab analyst performs a comprehensive metabolic panel, or CMP test in which he measures the blood level of 14 chemicals the code descriptor lists for the panel.	600	$10	$6K
J0185	Injection, aprepitant, 1 mg	5,980	$1	$6K
85025	A complete blood count (better known as a CBC) is a blood test request by a doctor that provides detailed information about various types of cells in a patient's blood. Usually a pathologist or a…	650	$10	$5.2K
M0010	Enhancing oncology model (eom) monthly enhanced oncology services (meos) payment for eom enhanced services	50	$70	$3.6K

Showing 1–10 of 53

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 53 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Oregon Distribution

Marc Uemura — 2 of 25 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Oregon

Full comparison — all codes billed, vs. state median

53 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J9271	5	30	8,700	$40	$430.9K
J9299	2	10	10,720	$20	$215.6K
J3490	38	50	40	$640	$42.9K
96413	15	90	150	$100	$18.2K
99214	3,405	6,070	80	$70	$10.3K
99233	1,204	1,310	70	$90	$9.1K
J0185	6	20	5,140	$1	$7.2K
99215	2,122	2,170	40	$100	$6.7K
99232	1,132	1,730	60	$60	$5.9K
96365	66	110	70	$50	$5.8K

Showing 1–10 of 53

Related Providers

Other providers that share a Tax Identification Number (TIN) with Marc Uemura, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Oncology Associates Of Oregon P C	OR	Hematology & Oncology Physician	$0	$2M
Michael Monticelli	CO	Hematology & Oncology Physician	$1.3M	$0
Bo Wang	OR	Hematology & Oncology Physician	$1.1M	$0
Keith Goldstein	OR	Medical Oncology Physician	$1M	$0
Jeff Sharman	OR	Medical Oncology Physician	$878.7K	$0
Benjamin Cho	OR	Medical Oncology Physician	$816K	$0
John Fitzharris	OR	Medical Oncology Physician	$672.6K	$0
Miho Dougherty	OR	Hematology & Oncology Physician	$633.2K	$0
Christopher Yasenchak	OR	Hematology & Oncology Physician	$604.5K	$0
Jonathan Gross	OR	Medical Oncology Physician	$533.5K	$0

Nearby Providers

Other providers in the same ZIP code as Marc Uemura, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Peacehealth Medical Group	OR	Family Medicine Physician	$0	$45.3M
Options Counseling Services Of Oregon	OR	Mental Health Counselor	$0	$25.9M
Eugene Emergency Physicians PC	OR	Emergency Medicine Physician	$0	$16.9M
Center For Family Development, Inc.	OR	Mental Health Counselor	$0	$15.6M
Laurel Hill Center	OR	Eyewear Supplier	$0	$14M
Looking Glass Community Services	OR	Mental Health Counselor	$0	$13.5M
Peacehealth	OR	General Acute Care Hospital	$0	$13.3M
Addiction Counseling And Education Services Inc.	OR	Mental Health Counselor	$0	$12.8M
Oregon Eye Consultants LLC	OR	Ophthalmology Physician	$0	$9.6M
Ch Mh Services (or), LLC	OR	Mental Health Clinic/Center (Including Community Mental Health Center)	$0	$9.4M

Marc Uemura — Billing Profile & Reimbursement Data

Sign up for Marc Uemura — Billing Profile & Reimbursement Data policy alerts

Marc Uemura — Billing Profile & Reimbursement Data

Sign up for Marc Uemura — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References